Ozaita A - Search Results

1

Densities of I2-imidazoline receptors, imidazoline receptor proteins, and MAO-B sites in human gliomas and pituitary adenomas.

Barturen F, Ventayol P, Ozaita A, Escribá PV, Meana JJ, García-Sevilla JA. Barturen F, et al. Among authors: ozaita a. Ann N Y Acad Sci. 1999 Jun 21;881:203-7. doi: 10.1111/j.1749-6632.1999.tb09361.x. Ann N Y Acad Sci. 1999. PMID: 10415917 No abstract available.

2

Pharmacological and immunological characterization of solubilized 130-140- and 66-kD imidazoline receptors in the rat brain.

Escribá PV, Ozaita A, Miralles A, Reis DJ, García-Sevilla JA. Escribá PV, et al. Among authors: ozaita a. Ann N Y Acad Sci. 1995 Jul 12;763:169-71. doi: 10.1111/j.1749-6632.1995.tb32403.x. Ann N Y Acad Sci. 1995. PMID: 7677327 Review. No abstract available.

3

Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.

Escribá PV, Ozaita A, García-Sevilla JA. Escribá PV, et al. Among authors: ozaita a. Ann N Y Acad Sci. 1999 Jun 21;881:8-25. doi: 10.1111/j.1749-6632.1999.tb09336.x. Ann N Y Acad Sci. 1999. PMID: 10415892 Review.

4

Lack of effect of reserpine on immunoreactive imidazoline receptor proteins in rat brain.

Miralles A, Ozaita A, Ribas C, García-Sevilla JA. Miralles A, et al. Among authors: ozaita a. Ann N Y Acad Sci. 1999 Jun 21;881:61-4. doi: 10.1111/j.1749-6632.1999.tb09342.x. Ann N Y Acad Sci. 1999. PMID: 10415898 No abstract available.

5

Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain.

Escribá PV, Ozaita A, Miralles A, Reis DJ, García-Sevilla JA. Escribá PV, et al. Among authors: ozaita a. Brain Res Mol Brain Res. 1995 Sep;32(2):187-96. doi: 10.1016/0169-328x(95)00074-3. Brain Res Mol Brain Res. 1995. PMID: 7500830 Free article.

6

Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.

Escribá PV, Alemany R, Sastre M, Olmos G, Ozaita A, García-Sevilla JA. Escribá PV, et al. Among authors: ozaita a. Br J Pharmacol. 1996 Aug;118(8):2029-36. doi: 10.1111/j.1476-5381.1996.tb15640.x. Br J Pharmacol. 1996. PMID: 8864539 Free PMC article.

7

Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.

Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA. Ozaita A, et al. Br J Pharmacol. 1997 Jul;121(5):901-12. doi: 10.1038/sj.bjp.0701214. Br J Pharmacol. 1997. PMID: 9222546 Free PMC article.

8

Role of lipid polymorphism in G protein-membrane interactions: nonlamellar-prone phospholipids and peripheral protein binding to membranes.

Escribá PV, Ozaita A, Ribas C, Miralles A, Fodor E, Farkas T, García-Sevilla JA. Escribá PV, et al. Among authors: ozaita a. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11375-80. doi: 10.1073/pnas.94.21.11375. Proc Natl Acad Sci U S A. 1997. PMID: 9326617 Free PMC article.

9

Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts.

Ozaita A, Escribá PV, Ventayol P, Murga C, Mayor F Jr, García-Sevilla JA. Ozaita A, et al. J Neurochem. 1998 Mar;70(3):1249-57. doi: 10.1046/j.1471-4159.1998.70031249.x. J Neurochem. 1998. PMID: 9489748 Free article.

10

The alkylating agent EEDQ facilitates protease-mediated degradation of the human brain alpha2A-adrenoceptor as revealed by a sequence-specific antibody.

Ozaita A, Escribá PV, García-Sevilla JA. Ozaita A, et al. Neurosci Lett. 1999 Mar 26;263(2-3):105-8. doi: 10.1016/s0304-3940(99)00118-4. Neurosci Lett. 1999. PMID: 10213146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters